Anixa Biosciences Inc (ANIX)

CIK 715446 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Anixa Biosciences Inc.

Recent SEC filings

FiledFormAccession number
Sep 11, 202640001493152-26-042302
Sep 9, 202610-Q0001493152-26-041963
Aug 3, 202640001493152-26-035751
Jul 29, 202640001493152-26-035122
Jul 28, 202640001493152-26-034952
Jul 27, 202640001493152-26-034772
Jul 27, 202640001493152-26-034723
Jul 21, 202640001493152-26-034027
Jul 20, 202640001493152-26-033949
Jul 16, 202640001493152-26-033461
Jul 13, 202640001493152-26-032961
Jun 17, 202640001493152-26-029030
Jun 16, 202640001493152-26-028827
Jun 10, 202610-Q0001493152-26-028105
Mar 11, 20268-K0001493152-26-009699
Mar 9, 202610-Q0001493152-26-009370
Feb 9, 20268-K0001493152-26-005702
Jan 29, 202640001493152-26-004148
Jan 28, 2026DEF 14A0001493152-26-004035
Jan 12, 202610-K0001493152-26-001845
Jan 12, 2026S-80001493152-26-001847
Jan 6, 202640001493152-26-000688
Jan 6, 2026SCHEDULE 13D/A0001493152-26-000691
Jan 6, 202640001493152-26-000689
Jan 6, 202640001493152-26-000685